University of Miami NeuroNEXT clinical center for new neurological treatments
Clinical Centers for the NINDS NeuroNEXT(Network of Excellence in Neuroscience Clinical Trials) Consortium
This project supports a University of Miami center that helps bring new treatments to adults with neurological conditions through coordinated clinical research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11137585 on NIH RePORTER |
What this research studies
The University of Miami site is part of the NeuroNEXT network that runs early, exploratory clinical studies of promising therapies for neurological disorders. As a clinical center, they recruit and enroll adult patients, collect clinical data and biomarkers, and follow standardized protocols to speed up study start-up and data quality. The team leverages local infrastructure and trained staff to support multiple NINDS-sponsored studies and to help young investigators gain experience in clinical-translational work. Being part of the network helps match patients to relevant studies and moves potential treatments through the testing pipeline more efficiently.
Who could benefit from this research
Good fit: Adults with neurological conditions who live in the South Florida area and meet the specific eligibility rules of a NeuroNEXT study would be the ideal candidates for participation.
Not a fit: People without neurological conditions, children, or adults who do not meet specific trial inclusion criteria likely would not benefit from enrollment at this site.
Why it matters
Potential benefit: If successful, this center could speed patient access to new neurological treatments and improve how quickly promising therapies move from research to care.
How similar studies have performed: NeuroNEXT is an established NINDS network with prior early-phase studies that have helped advance candidate therapies toward later trials.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Benatar, Michael — University of Miami School of Medicine
- Study coordinator: Benatar, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.